News from the diabetes care industry
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 56 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1357-8170
No coin nor oath required. For personal study only.
β¦ Synopsis
News from the diabetes care industry
Humalog cleared for treatment of children and adolescents
The European Commission has approved an important new indication for Humalog (insulin lispro): the treatment of diabetes in children and adolescents. At the same time, the Commission approved the claim by the manufacturer, Eli Lilly and Co, that use of Humalog in subcutaneous insulin infusion pumps reduces HbA 1c more effectively than human regular, or soluble, insulins. Humalog has been approved for use in CSII since April 1998.
π SIMILAR VOLUMES
The aim of this study was to identify and quantify barriers to diabetes care perceived by diabetic subjects from a multiethnic, urban community (mainly New Zealand Europeans, Maori, and Pacific Islanders). A qualitative survey including 57 diabetic subjects and health care providers from a diverse r